Jacobs Levy Equity Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-47,485
| Closed | -$486K | – | 1001 |
|
|
2023
Q3 | $486K | Buy |
47,485
+21,462
| +82% | +$220K | ﹤0.01% | 806 |
|
|
2023
Q2 | $411K | Sell |
26,023
-207
| -0.8% | -$3.27K | ﹤0.01% | 848 |
|
|
2023
Q1 | $593K | Buy |
+26,230
| New | +$593K | ﹤0.01% | 777 |
|
|
2021
Q4 | – | Sell |
-414
| Closed | -$143K | – | 995 |
|
|
2021
Q3 | $143K | Hold |
414
| – | – | ﹤0.01% | 1007 |
|
|
2021
Q2 | $156K | Hold |
414
| – | – | ﹤0.01% | 1000 |
|
|
2021
Q1 | $129K | Sell |
414
-2,387
| -85% | -$744K | ﹤0.01% | 990 |
|
|
2020
Q4 | $701K | Sell |
2,801
-2,071
| -43% | -$518K | 0.01% | 802 |
|
|
2020
Q3 | $900K | Buy |
4,872
+516
| +12% | +$95.3K | 0.01% | 684 |
|
|
2020
Q2 | $1.09M | Buy |
4,356
+3,567
| +452% | +$892K | 0.01% | 653 |
|
|
2020
Q1 | $143K | Buy |
+789
| New | +$143K | ﹤0.01% | 930 |
|